sentences:  "In vitro" and "in vivo" experiments suggest a response of CR3 and CR4 to enable complement-dependent cell cytotoxicity towards antibody-coated cancer cells.Such biological therapeutic targeting is characterized by lowering autoimmune inflammation or enhancing anti-cancer vaccination effects.Leukadherin-1, a CR3 agonist molecule, has been shown to suppress human innate inflammatory signals.